United Kingdom· GB-APID-7276411000001107
Mitomycin-C Kyowa 2mg powder for solution for injection vials
A mitomycin product containing mitomycin, registered in United Kingdom by Kyowa Kirin Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mitomycin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01DC03 (mitomycin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Mitomycin · ATC L01DC03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mitomycin costs, country by country.
Normalised to the WHO defined daily dose (4.29 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mitomycin · price per daily dose (4.29 mg)
USD · FX 28 Sept 2026
- CH Switzerland$32.20
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mitomycin
- Manufacturer
- Kyowa Kirin Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01DC03
- ATC class
- Mitomycin
- Defined daily dose
- 4.29 mg, intravesikal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin4987057155418
- gtin5038903000570
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
193 interactions on record for mitomycin.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mitomycin · interactions on record
193 records
- 31 severe
- 101 moderate
- 15 minor
- 46 info
Most severe, free to view
- CladribineL01BB04severe
- FluorouracilL01BC02severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mitomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMitomycine-C Kyowa 2 mgTakeda Belgium
- United StatesMitomycinBluePoint Laboratories
- GermanyMitemSubstipharm
- CzechiaMITOMYCIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SpainMITOMICINA ACCORD 10 MG POLVO PARA SOLUCION INTRAVESICAL Y PARA SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- FinlandMitomycin AccordAccord Healthcare B.V.
- NetherlandsMitomycine Accord 10 mg, poeder voor oplossing voor injectie / infusie of intravesicaal gebruikAccord Healthcare B.V.
- NorwayMitomycin medacMedac - Gesellschaft für klinische Spezialpräparate Gmbh - Wedel
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mitomycin Medac
- Belgium · Mitomycin Accord Healthcare, Mitomycin Medac
- Bulgaria · Митомицин Акорд
- Cyprus · Mitomycin Accord, Mitomycine Substipharm
- Czechia · Mitomycin Accord, Mitomycin Medac
- Germany · Mitem, Mito-Apogepha
- Denmark · Mitomycin Medac
- Estonia · Mitomycin Accord, Mitomycin Medac
- Spain · Mitomicina Accord, Mitomicina Aurovitas
- Finland · Mitomycin Accord, Mitomycin Medac
- France · Mitomycine Accord, Mitomycine Medac
- Ireland · Mitomycin Medac
- Iceland · Mitomycin Medac
- Italy · Mitomicina Accord, Mitomicina Medac
- Lithuania · Mitomycin Medac
- Latvia · Mitomycin Medac
- Malta · Mitomycine Substipharm
- Netherlands · Mitomycine Accord, Mitomycine Medac
- Norway · Mitomycin Medac, Mitomycin Substipharm
- Poland · Mitomycin Accord
- Portugal · Mitomicina Accord, Mitomicina Accord Healthcare
- Romania · Mitomicină Accord
- Sweden · Mitomycin Medac, Mitomycin Substipharm
- Slovenia · Mitomicin Accord, Mitomicin Medac
- Slovakia · Mitomycin Accord, Mitomycin Medac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b24a8d15-dbd8-48ea-8dc3-4479b5439740 GET /v1/drugs/b24a8d15-dbd8-48ea-8dc3-4479b5439740?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7276411000001107",
"desc": "Mitomycin-C Kyowa 2mg powder for solution for injection vials (Kyowa Kirin Ltd)",
"form": "Powder for solution for injection",
"vpid": "41792511000001108",
"source": "dmd",
"vtm_id": "776807008",
"strength": "2 mg",
"substance": "Mitomycin",
"ingredient": "Mitomycin",
"supplier_code": "3558501000001106"
}See everything about mitomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.